共 45 条
[1]
Baker C.J., Edwards M.S., Group B streptococcal infections, Infectious Diseases of the Fetus and Newborn Infant, pp. 742-811, (1990)
[2]
Rubens C.J., Type III capsular polysaccharide of group B streptococci: Role in virulence and the molecular basis of capsule expression, Molecular Genetics of Bacterial Pathogenesis, pp. 327-339, (1994)
[3]
Payne N.R., Burke B.A., Day D.L., Christenson P.D., Thompson T.R., Ferrieri P., Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome, Pediatr Infect Dis J, 7, pp. 836-847, (1988)
[4]
Yeung M.K., Mattingly S.J., Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci, Infect Immun, 44, pp. 217-221, (1984)
[5]
Rubens C.E., Wessels M.R., Heggen L.M., Dl K., Transposon mutagenesis of group B streptococcal type III capsular polysaccharide: Correlation of capsule expression with virulence, Proc Natl Acad Sci USA, 84, pp. 7208-7212, (1987)
[6]
Wessels M.R., Rubens C.E., Benedi V.J., Kasper D.L., Definition of a bacterial virulence factor: Sialylation of the group B streptococcal capsule, Proc Natl Acad Sci USA, 86, pp. 8983-8987, (1989)
[7]
Catlin B., Haemophilus influenzae in cultures of cerebrospinal fluid, Amer J Dis Child, 120, pp. 203-210, (1970)
[8]
Macleod C.M., Krauss M.R., Relation to virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro, J Exp Med, 92, pp. 1-9, (1950)
[9]
Hakansson S., Holm S.E., Wagner M., Density profile of group B streptococci, type III, and its possible relation to enhanced virulence, J Clin Microbiol, 25, pp. 714-718, (1987)
[10]
Hakansson S., Granlund-Edstedt M., Sellin M., Holm S.E., Demonstration and characterization of buoyant density subpopulations of group B streptococcus type III, J Infect Dis, 161, pp. 741-746, (1990)